Results for “”

Entry Author Date Location
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More 05/01/20 National
Goldfinch Bio Adds Kyle Kuvalanka, Lori Rudolph-Owen to C-Suite 04/30/20 Boston
Intellia Therapeutics Taps Semma’s Lebwohl as Chief Medical Officer 04/30/20 Boston
Adicet Aims to Advance CAR-T Therapies in Reverse Merger with resTORbio 04/29/20 Boston
Radius Health CEO Hoeiland Steps Down, Martin Named Successor 04/29/20 Boston
Forma Therapeutics Taps Ex-Seres Exec Cook as Chief Scientific Officer 04/29/20 Boston
AMAG Pharma Appoints Rainier’s Myers to Succeed CEO William Heiden 04/28/20 Boston
At Rome Therapeutics, Kapeller Aims to Turn “Junk” Into New Drugs 04/28/20 Boston
Xilio Taps Former Tesaro Exec Martin Huber as Chief Medical Officer 04/27/20 Boston
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More 04/24/20 National
Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory 04/23/20 Boston
Biogen Pushes Finalized Filing for Alzheimer’s Drug to Third Quarter 04/22/20 Boston
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) 04/22/20 National
New COVID-19 Special Reports Explore Clinical Research During the Pandemic 04/21/20 Boston
War Paint to Bone Paint: MIT Spinout Aims to Transform Regenerative Meds 04/21/20 Boston
Ohana Bio Adds Ramiro Castro-Santamaria as Chief Medical Officer 04/20/20 Boston
COVID-19 Vax Efforts Aim to Balance Speed, Efficacy in Race to Market 04/17/20 National
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
TearClear Taps Former Shire Executive Robert Dempsey as CEO 04/16/20 Boston
Neurology at Forefront of FDA’s Complex Innovative Trial Design Pilot 04/16/20 National
Ex-Regeneron Exec Graham Named Evelo Bio Chief Development Officer 04/15/20 Boston
With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer 04/15/20 Boston
Cerevance Raises $45M to Advance Brain Disease Research & Development 04/14/20 Boston
GSK and Sanofi Team Up on COVID-19 Vaccine, Aim for Clinic This Year 04/14/20 National
Blackstone Pays Alnylam $1B to Grab a Stake in RNAi Drug Inclisiran 04/13/20 Boston
Akero Heads to Top of Class in NASH; Genfit Says Pandemic Won’t Delay Data 04/10/20 National
Tango Therapeutics Appoints Beckman as Chief Financial Officer 04/10/20 Boston
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Pfizer, BioNTech Say mRNA COVID-19 Vaccine Trials May Start This Month 04/09/20 National
Tango Adds $60M in CRISPR Hunt for Synthetically Lethal Cancer Drugs 04/09/20 Boston
Page 2 of 668 « previous page · next page »